Risk of Systemic Adverse Events Following Intravitreal...

  • Main
  • 2020 / 8
  • Risk of Systemic Adverse Events Following Intravitreal...
Ophthalmology 2020 / 8

Risk of Systemic Adverse Events Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice

Maloney, Maya H., Payne, Stephanie R., Herrin, Jeph, Sangaralingham, Lindsey R., Shah, Nilay D., Barkmeier, Andrew J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Ophthalmology
DOI:
10.1016/j.ophtha.2020.07.062
Date:
August, 2020
File:
PDF, 458 KB
2020
Conversion to is in progress
Conversion to is failed